<b>Gapping up <br/>In reaction to earnings/guidance:</b> DD +6.3%, (issues guidance; Chair and CEO of DuPont, announced that she will retire from the company effective October 16), MNK +5.8%, SIMO +3.7%, PEP +2.6%<br/><br/><b>M&A news:</b> PMCS +32.6% (PMC-Sierra to be acquired by Skyworks (SWKS) for $10.50 per share), STRZA +7.2% (LA Times reporting co and Lions Gate Entertainment (LGF) are in advanced merger talks), SBGL +5.5% (offers $294 mln to acquire Aquarius Platinum Limited; Aquarius board intends to vote in favor of the offer), SWKS +1.8% (acquiring PMCS for $10.50/sh; also reported BTE Q4 guidance), LGF +1.1%<br/><br/><b>Select metals/mining stocks trading higher:</b> CLF +6.1%, AU +2.7%, HMY +2.1%, GFI +2.1%, X +0.8%<br/><br/><b>Other news:</b> NVCR +15.5% (receives FDA approval for Optune in Combination with Temozolomide in newly diagnosed glioblastoma patients), EXEL +8.8% (reports positive overall survival results from Phase 3 Trial of Cobimetinib in combination with Vemurafenib), RGLS +8.4% (to present additional preclinical data supporting RG-012 as novel microRNA therapeutic in development for Alport Syndrome at ASN's Kidney Week), ARNA +4.7% (announces that, at the request of the Board, Jack Lief, President and CEO, has retired from the company; Harry F. Hixson appointed interim CEO), ALKS +4.2% (FDA approved ARISTADA for the treatment of schizophrenia), AMDA +3.8% (files for ~29.53 mln share common stock offering by selling shareholders), RKUS +3.2% (to replace CYBX in the S&P SmallCap 600), WPRT +1.8% (co's joint venture Cummins Westport (CMI) announced the new ISL G Near Zero NOx natural gas engine), STM +1.7% (semi peer, in symp with PMCS), PBR +1.2% (adjusts its finnacing planning for 2015, 2016), CONN +0.9% (Director disclosed purchase of 12000 shares, worth total of $291K)<br/><br/><b>Analyst comments:</b> NUVA +1.6% (upgraded to Outperform from Market Perform at BMO Capital), FDX +0.7% (upgraded to Buy from Hold at Stifel), CSAL +0.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance: </b>ILMN -18.5%, HAE -12.2%, TCS -8.8%, RDWR -7.8%, PBF -1.4%<br/><b><br/>Select fan favorite names showing weakness pre-mkt:</b> FEYE -1.5%, TWTR -1.3%, GILD -1.1%, NFLX -1.1%, BABA -1.1%, AAPL -0.7%, FB -0.5%<br/><br/><b>Other news: </b>EXAS -32.5% (disappointing USPSTF draft on colon cancer screening recommendations), EXXI -8.3% (filed for $500 mln mixed securities shelf offering), CTRV -4.9% (pulling back following yday's gains), SRPT -4.2% ( to offer up to $125 mln of its common stock in an underwritten public offering), BBLU -3.2% (disclosed material weakness, says previously issued audit reports should no longer be relied upon), TAP -2.4% (SABMiller plc Management might fight proposed In Bev (BUD) bid, according to NY Post), MT -2.2% (pulling back following recent strength), LGIH -1.7% (reports Q3 closings), PBF -1.4% (commenced an underwritten public offering of 10 mln shares of its Class A common stock), SUNE -1.3% (pulling back following recent strength), BHP -1.3% (may be attributed to Aus Trade Balance, exports to China hit 3-month low), RIO -0.9% (may be attributed to Aus Trade Balance, exports to China hit 3-month low)<br/><br/><b>Analyst comments:</b> FFIV -2.4% (initiated with a Sell at Citigroup; tgt $105), TSLA -2.2% (target lowered to $450 from $465 at Morgan Stanley)<br/><br/>Briefing.com